377 related articles for article (PubMed ID: 33941653)
1. MYO1F Regulates IgE and MRGPRX2-Dependent Mast Cell Exocytosis.
Navinés-Ferrer A; Ainsua-Enrich E; Serrano-Candelas E; Proaño-Pérez E; Muñoz-Cano R; Gastaminza G; Olivera A; Martin M
J Immunol; 2021 May; 206(10):2277-2289. PubMed ID: 33941653
[TBL] [Abstract][Full Text] [Related]
2. Myo1f, an Unconventional Long-Tailed Myosin, Is a New Partner for the Adaptor 3BP2 Involved in Mast Cell Migration.
Navinés-Ferrer A; Ainsua-Enrich E; Serrano-Candelas E; Sayós J; Martin M
Front Immunol; 2019; 10():1058. PubMed ID: 31143189
[TBL] [Abstract][Full Text] [Related]
3. Mast cell degranulation via MRGPRX2 by isolated human albumin fragments.
Karhu T; Akiyama K; Vuolteenaho O; Bergmann U; Naito T; Tatemoto K; Herzig KH
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2530-2534. PubMed ID: 28844982
[TBL] [Abstract][Full Text] [Related]
4. Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2.
Hermans MAW; van Stigt AC; van de Meerendonk S; Schrijver B; van Daele PLA; van Hagen PM; van Splunter M; Dik WA
Front Immunol; 2021; 12():625284. PubMed ID: 33790895
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of Compound 48/80-Mediated Itch and LL-37-Induced Inflammation by a Single-Stranded Oligonucleotide.
Dondalska A; Rönnberg E; Ma H; Pålsson SA; Magnusdottir E; Gao T; Adam L; Lerner EA; Nilsson G; Lagerström M; Spetz AL
Front Immunol; 2020; 11():559589. PubMed ID: 33101278
[TBL] [Abstract][Full Text] [Related]
6. IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming.
Wang Z; Guhl S; Franke K; Artuc M; Zuberbier T; Babina M
Cells; 2019 Apr; 8(4):. PubMed ID: 30979016
[TBL] [Abstract][Full Text] [Related]
7. MrgprX2 regulates mast cell degranulation through PI3K/AKT and PLCγ signaling in pseudo-allergic reactions.
Zhang F; Hong F; Wang L; Fu R; Qi J; Yu B
Int Immunopharmacol; 2022 Jan; 102():108389. PubMed ID: 34920312
[TBL] [Abstract][Full Text] [Related]
8. Thimerosal induces skin pseudo-allergic reaction via Mas-related G-protein coupled receptor B2.
Peng B; Che D; Hao Y; Zheng Y; Liu R; Qian Y; Cao J; Wang J; Zhang Y; He L; Geng S
J Dermatol Sci; 2019 Sep; 95(3):99-106. PubMed ID: 31558225
[TBL] [Abstract][Full Text] [Related]
9. Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones.
Elst J; Maurer M; Sabato V; Faber MA; Bridts CH; Mertens C; Van Houdt M; Van Gasse AL; van der Poorten MM; De Puysseleyr LP; Hagendorens MM; Van Tendeloo VF; Lion E; Campillo-Davo D; Ebo DG
Front Immunol; 2021; 12():668962. PubMed ID: 34385999
[TBL] [Abstract][Full Text] [Related]
10. Differential Regulation of Mas-Related G Protein-Coupled Receptor X2-Mediated Mast Cell Degranulation by Antimicrobial Host Defense Peptides and Porphyromonas gingivalis Lipopolysaccharide.
Gupta K; Idahosa C; Roy S; Lee D; Subramanian H; Dhingra A; Boesze-Battaglia K; Korostoff J; Ali H
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28694291
[No Abstract] [Full Text] [Related]
11. Caffeic acid phenethyl ester inhibits pseudo-allergic reactions via inhibition of MRGPRX2/MrgprB2-dependent mast cell degranulation.
Adhikari N; Shim WS
Arch Pharm Res; 2022 Sep; 45(9):644-657. PubMed ID: 36183260
[TBL] [Abstract][Full Text] [Related]
12. MRGPRX2 activation as a rapid, high-throughput mechanistic-based approach for detecting peptide-mediated human mast cell degranulation liabilities.
Lafleur MA; Werner J; Fort M; Lobenhofer EK; Balazs M; Goyos A
J Immunotoxicol; 2020 Dec; 17(1):110-121. PubMed ID: 32525431
[TBL] [Abstract][Full Text] [Related]
13. All-trans-retinoic acid activated mast cells via Mas-related G-protein-coupled receptor-X2 in retinoid dermatitis.
Zheng Y; Che D; Peng B; Hao Y; Zhang X; He L; Geng S
Contact Dermatitis; 2019 Sep; 81(3):184-193. PubMed ID: 31006867
[TBL] [Abstract][Full Text] [Related]
14. Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent.
Liu R; Hu S; Zhang Y; Che D; Cao J; Wang J; Zhao T; Jia Q; Wang N; Zhang T
Int Immunopharmacol; 2019 May; 70():417-427. PubMed ID: 30856392
[TBL] [Abstract][Full Text] [Related]
15. MRGPRX2 and Adverse Drug Reactions.
McNeil BD
Front Immunol; 2021; 12():676354. PubMed ID: 34421893
[TBL] [Abstract][Full Text] [Related]
16. Lactic acid suppresses MRGPRX2 mediated mast cell responses.
Syed M; Kammala AK; Callahan B; Oskeritzian CA; Subramanian H
Cell Immunol; 2021 Oct; 368():104422. PubMed ID: 34399172
[TBL] [Abstract][Full Text] [Related]
17. DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis.
Kunimura K; Akiyoshi S; Uruno T; Matsubara K; Sakata D; Morino K; Hirotani K; Fukui Y
J Allergy Clin Immunol; 2023 Jun; 151(6):1585-1594.e9. PubMed ID: 36804596
[TBL] [Abstract][Full Text] [Related]
18. MRGPRX2 is negatively targeted by SCF and IL-4 to diminish pseudo-allergic stimulation of skin mast cells in culture.
Babina M; Wang Z; Artuc M; Guhl S; Zuberbier T
Exp Dermatol; 2018 Nov; 27(11):1298-1303. PubMed ID: 30091263
[TBL] [Abstract][Full Text] [Related]
19. Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target.
Chen E; Chuang LS; Giri M; Villaverde N; Hsu NY; Sabic K; Joshowitz S; Gettler K; Nayar S; Chai Z; Alter IL; Chasteau CC; Korie UM; Dzedzik S; Thin TH; Jain A; Moscati A; Bongers G; Duerr RH; Silverberg MS; Brant SR; Rioux JD; Peter I; Schumm LP; Haritunians T; McGovern DP; Itan Y; Cho JH
Gastroenterology; 2021 Apr; 160(5):1709-1724. PubMed ID: 33421512
[TBL] [Abstract][Full Text] [Related]
20. Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions.
Porebski G; Kwiecien K; Pawica M; Kwitniewski M
Front Immunol; 2018; 9():3027. PubMed ID: 30619367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
